Amid swirling speculation, Bausch + Lomb ($BLCO), a global leader in the contact lens supply industry, is reportedly ...
GlobalData on MSN1mon
Bausch + Lomb wins FDA nod for enVista Envy range of intraocular lensesEye health firm Bausch + Lomb has received marketing approval for its full range of enVista Envy vision intraocular lenses ...
Comfort was the name of the game when OT spoke with contact lens manufacturers and suppliers about recent trends and launches ...
Designed to help maximize efficiencies for eye care practices while enhancing the patient experience, Opal provides a streamlined ordering process for Bausch + Lomb contact lenses, with select ...
It isn't known whether Bausch + Lomb and/or Goldman is in contact with either Blackstone ... range of its enVista Envy vision intraocoular lenses (IOLs). These are implanted in the eye to treat ...
Bausch + Lomb scaled up its revenue guidance for the year after swinging to a profit in the latest quarter on the back of sales growth in each of its business segments.
Bausch Health shares rose Thursday morning after the company raised its full year outlook following a better-than-expected third-quarter performance. Shares traded over 11% higher in Toronto at 12.68 ...
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Bausch + Lomb Corporation (BLCO – Research Report) yesterday and set a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback